Cargando…

Altered intercellular communication and extracellular matrix signaling as a potential disease mechanism in human hypertrophic cardiomyopathy

Hypertrophic cardiomyopathy (HCM) is considered a primary disorder of the sarcomere resulting in unexplained left ventricular hypertrophy but the paradoxical association of nonmyocyte phenotypes such as fibrosis, mitral valve anomalies and microvascular occlusion is unexplained. To understand the in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Larson, Amy, Codden, Christina J., Huggins, Gordon S., Rastegar, Hassan, Chen, Frederick Y., Maron, Barry J., Rowin, Ethan J., Maron, Martin S., Chin, Michael T.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8956620/ https://www.ncbi.nlm.nih.gov/pubmed/35338173 http://dx.doi.org/10.1038/s41598-022-08561-x

Ejemplares similares

Differing strategies for sudden death prevention in hypertrophic cardiomyopathy
por: Maron, Martin S, et al.
Publicado: (2023)

Plasma Proteomic Profiling in Hypertrophic Cardiomyopathy Patients before and after Surgical Myectomy Reveals Post-Procedural Reduction in Systemic Inflammation
por: Larson, Amy, et al.
Publicado: (2021)

Is Hypertrophic Cardiomyopathy Always a Familial and Inherited Disease?
por: Bonaventura, Jiri, et al.
Publicado: (2023)

Common and Distinctive Intercellular Communication Patterns in Human Obstructive and Nonobstructive Hypertrophic Cardiomyopathy
por: Codden, Christina J., et al.
Publicado: (2022)

What Causes Hypertrophic Cardiomyopathy?
por: Maron, Bradley A., et al.
Publicado: (2022)

Single Nucleus RNA-sequencing Reveals Altered Intercellular Communication and Dendritic Cell Activation in Nonobstructive Hypertrophic Cardiomyopathy
por: Codden, Christina J, et al.
Publicado: (2022)

Winter Is Coming: The Slippery Slope of Defining Disease and the Implications for Hypertrophic Cardiomyopathy
por: Rowin, Ethan J., et al.
Publicado: (2022)

The necessity for full ventricular coverage with noncontrast T1 mapping in hypertrophic cardiomyopathy
por: Rowin, Ethan, et al.
Publicado: (2013)

Future Role of New Negative Inotropic Agents in the Era of Established Surgical Myectomy for Symptomatic Obstructive Hypertrophic Cardiomyopathy
por: Maron, Barry J., et al.
Publicado: (2022)

Analysis of risk stratification and prevention of sudden death in pediatric patients with hypertrophic cardiomyopathy: Dilemmas and clarity
por: Bonaventura, Jiri, et al.
Publicado: (2023)

Noncontrast T1 values do not correlate to clinically relevant variables in patients with hypertrophic cardiomyopathy
por: Rowin, Ethan, et al.
Publicado: (2013)

Impact of Sex on Clinical Course and Survival in the Contemporary Treatment Era for Hypertrophic Cardiomyopathy
por: Rowin, Ethan J., et al.
Publicado: (2019)

Machine Learning for Predicting Heart Failure Progression in Hypertrophic Cardiomyopathy
por: Fahmy, Ahmed S., et al.
Publicado: (2021)

Individualized interactomes for network-based precision medicine in hypertrophic cardiomyopathy with implications for other clinical pathophenotypes
por: Maron, Bradley A., et al.
Publicado: (2021)

Subcutaneous Implantable Cardioverter Defibrillator in Patients With Hypertrophic Cardiomyopathy: An Initial Experience
por: Weinstock, Jonathan, et al.
Publicado: (2016)

Echocardiographic profiles in hypertrophic cardiomyopathy: imaging beyond the septum and systolic anterior motion
por: Pandian, Natesa G, et al.
Publicado: (2015)

Radiomics and deep learning for myocardial scar screening in hypertrophic cardiomyopathy
por: Fahmy, Ahmed S., et al.
Publicado: (2022)

Author Correction: Individualized interactomes for network-based precision medicine in hypertrophic cardiomyopathy with implications for other clinical pathophenotypes
por: Maron, Bradley A., et al.
Publicado: (2022)

Clinical Characteristics and Healthcare Resource Utilization among Patients with Obstructive Hypertrophic Cardiomyopathy Treated in a Range of Settings in the United States
por: Butzner, Michael, et al.
Publicado: (2022)

Role of Implantable Cardioverter Defibrillators in the Treatment of Hypertrophic Cardiomyopathy
por: Ghosh, Joydeep, et al.
Publicado: (2005)

Feline Hypertrophic Cardiomyopathy: A Spontaneous Large Animal Model of Human HCM
por: Freeman, Lisa M., et al.
Publicado: (2017)

Thinking Outside the Heart to Treat Atrial Fibrillation in Hypertrophic Cardiomyopathy
por: Rowin, Ethan J., et al.
Publicado: (2020)

Role of the Extracellular Matrix in the Pathogenesis of Hypertrophic Cardiomyopathy
por: Marian, Ali J.
Publicado: (2019)

Clinical Utility of Cardiovascular Magnetic Resonance in Hypertrophic Cardiomyopathy
por: Maron, Martin S
Publicado: (2012)

Out With the Old and in With the New: Not So Fast in Hypertrophic Cardiomyopathy
por: Maron, Martin S.
Publicado: (2019)

Cardiovascular Diseases That Have Emerged From the Darkness
por: Maron, Barry J., et al.
Publicado: (2021)

Single Cell Transcriptomic Analysis in a Mouse Model of Barth Syndrome Reveals Cell-Specific Alterations in Gene Expression and Intercellular Communication
por: Perera, Gayani, et al.
Publicado: (2023)

Late gadolinium enhancement is compatible with advanced age in hypertrophic cardiomyopathy: implications for risk stratification of sudden death
por: Chan, Raymond H, et al.
Publicado: (2012)

Late gadolinium enhancement score (LGE-Score) for prediction of extensive late gadolinium enhancement in hypertrophic cardiomyopathy
por: Chan, Raymond H, et al.
Publicado: (2015)

Syndrome of Reversible Cardiogenic Shock and Left Ventricular Ballooning in Obstructive Hypertrophic Cardiomyopathy
por: Sherrid, Mark V., et al.
Publicado: (2021)

Clinicopathological profiles of progressive heart failure in hypertrophic cardiomyopathy
por: Melacini, Paola, et al.
Publicado: (2010)

Effect of Left Ventricular Outflow Tract Obstruction on Left Atrial Mechanics in Hypertrophic Cardiomyopathy
por: Williams, Lynne K., et al.
Publicado: (2015)

Screening for hypertrophic cardiomyopathy: a cost analysis of echocardiography, cardiac magnetic resonance and genetic testing
por: Hauser, Thomas H, et al.
Publicado: (2009)

Characterization of patients with massive hypertrophic cardiomyopathy using contrast-enhanced magnetic resonance imaging: does contrast provide additional information?
por: Chan, Raymond H, et al.
Publicado: (2012)

Cardiac Sarcoidosis Mimicking Hypertrophic Cardiomyopathy: The Importance of Cardiac Magnetic Resonance Imaging
por: Feldman, Daniel R., et al.
Publicado: (2020)

Characterization of tissue heterogeneity by contrast-enhanced cardiovascular magnetic resonance imaging is a powerful predictor of ventricular tachyarrhythmias on ambulatory holter ECG in hypertrophic cardiomyopathy
por: Harrigan, Caitlin J, et al.
Publicado: (2009)

Parasite Extracellular Vesicles: Mediators of Intercellular Communication
por: Twu, Olivia, et al.
Publicado: (2014)

A maladaptive feedback mechanism between the extracellular matrix and cytoskeleton contributes to hypertrophic cardiomyopathy pathophysiology
por: Viola, Helena M., et al.
Publicado: (2023)

An Emerging Frontier in Intercellular Communication: Extracellular Vesicles in Regeneration
por: Avalos, Priscilla N., et al.
Publicado: (2022)

Hypertrophic cardiomyopathy in myosin-binding protein C (MYBPC3) Icelandic founder mutation carriers
por: Adalsteinsdottir, Berglind, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_1k2aodacpof5ss5dto67maqp4r